A clerodane diterpene from Polyalthia longifolia as a modifying agent of the resistance of methicillin resistant Staphylococcus aureus
Related Experiment Video
Updated: Mar 21, 2026

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
Vivek Kumar Gupta1, Nimisha Tiwari1, Priyanka Gupta1
1Molecular Bioprospection Department, CSIR-Central Institute of Medicinal and Aromatic Plants, P.O. CIMAP, Lucknow-226015, India.
Background:
Staphylococcus aureus infections are raising serious concern across the world. The effectiveness of conventional drugs is continuously decreasing due to global emergence of multidrug resistance (MDR) and therefore, new resistance-modifying agents (RMAs) are highly needed.
Hypothesis:
Clerodane diterpene 16α-hydroxycleroda-3,13(14)-Z-dien-15,16-olide (CD) from leaves of Polyalthia longifolia (Sonn.) Thwaites (Annonaceae) as RAM will be useful in improving the current treatment strategies for staphylococcal infections.
Study Design:
In the present study, we determine the resistance-modifying activity of CD using clinical isolates of MRSA. Further, the influence of CD on innate immune response was also evaluated in vitro and in vivo. The nature of potential interactions was determined by fractional inhibitory concentration indices (FICIs) calculated from microdilution assays and time-kill curves.
Results:
The result of in vitro combination study showed that CD significantly reduced MIC of fluoroquinolones up to 16-folds (FICI 0.315-0.500), while in S. aureus infected Swiss albino mice model, combination of CD with norfloxacin, significantly (p<0.01, p<0.001) lowered the systemic microbial burden in blood, liver, kidney, lung and spleen tissues in comparison to CD, norfloxacin alone as well as untreated control. Flow cytometry analysis clearly showed that CD significantly inhibited EtBr efflux and extended post-antibiotic effect. In qRT-PCR analysis, CD alone as well as in combination, significantly modulated the expression of various efflux pump genes including norA up to 2-fold in clinical isolate MRSA-ST2071. Further, the in vitro combination study of the CD (10, 5, 2.5µg/ml) along with the norfloxacin (10µg/ml) depicted a significant decline in the pro-inflammatory cytokines, IL6 and TNF-α. In septic shock mice model, CD did not exhibit any significant changes in the level of pro-inflammatory cytokines.
Conclusion:
This is the first report on drug resistance-modifying potential of CD through inhibition of MDR efflux pump.
Insights
Clerodane diterpene (CD) enhances antibiotic effectiveness against drug-resistant Staphylococcus aureus by inhibiting efflux pumps. This natural compound shows promise in combating rising antimicrobial resistance, offering new hope for treating staphylococcal infections.
Area of Science:
- Pharmacology
- Microbiology
- Natural Products Chemistry
Background:
- Staphylococcus aureus infections pose a global health threat.
- Multidrug resistance (MDR) compromises conventional antibiotic efficacy.
- Novel resistance-modifying agents (RMAs) are crucial for effective treatment.
Purpose of the Study:
- To evaluate the resistance-modifying activity of Clerodane diterpene (CD) from Polyalthia longifolia against MRSA.
- To assess the impact of CD on the innate immune response in vitro and in vivo.
- To elucidate the mechanism of action, including efflux pump inhibition.
Main Methods:
- In vitro susceptibility testing using microdilution assays and time-kill curves.
- In vivo efficacy studies in a Staphylococcus aureus-infected Swiss albino mice model.
- Flow cytometry for efflux pump activity and qRT-PCR for gene expression analysis.
Main Results:
- CD significantly reduced fluoroquinolone minimum inhibitory concentrations (MICs) up to 16-fold.
- Combination therapy with CD and norfloxacin lowered bacterial burden in multiple organs in vivo.
- CD inhibited ethidium bromide efflux and modulated norA efflux pump gene expression.
Conclusions:
- CD demonstrates significant drug resistance-modifying potential by inhibiting MDR efflux pumps.
- This study is the first to report the efflux pump inhibitory activity of CD.
- CD represents a promising natural compound for enhancing current antimicrobial therapies.
More Related Videos
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Olefin Metathesis Polymerization: Acyclic Diene Metathesis (ADMET)
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...
Chemical Agents for Microbial Control
Staphylococcal Skin Infections
Development of Antibiotic Resistance

